Skip to main navigation Skip to search Skip to main content

Porous silicon nanoparticles for applications in nano-medicine

Research output: Chapter in Book/Report/Conference proceedingEncyclopaedia / Dictionary EntryOtherpeer-review

Abstract

Drug delivery using nanosized materials holds significant potential to resolve challenges faced by conventional enteral and parental therapeutic administration, including poor drug solubility and off-target toxic effects. Porous silicon (pSi) nanostructures possess large surface areas in relation to volume and exhibit high biocompatibility. Tunable pore size and versatile surface functionalisation allows carriers to be created to match drug characteristics, maximising loading capacity. This chapter reviews the fabrication of pSi nanoparticles and their use for targeted drug delivery. Particular emphasis is placed on surface functionalisation regimes typically employed to construct biocompatible nanoparticles. The qualification of candidate pSi nanoparticles as biocompatible and fit-for-purpose, required for progression to therapeutic use, are discussed. We particularly focus on the application of pSi nanocarriers for cancer therapies and chronic wound healing.

Original languageEnglish
Title of host publicationComprehensive Nanoscience and Nanotechnology
PublisherElsevier
Chapter3.11
Pages211-226
Number of pages16
Volume3
Edition2
ISBN (Electronic)9780128122952
ISBN (Print)9780128122969
DOIs
Publication statusPublished - 1 Jan 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-infectives
  • Biocompatibility
  • Cancer therapy
  • Drug delivery
  • Gene delivery
  • Nano-medicine
  • Nanoparticles
  • Nitrous oxide
  • Porous silicon
  • siRNA
  • Surface functionalization

Cite this